| Bioactivity | 5,6-DCl-cBIMP, a cyclic adenosine monophosphate analog, can act as an agonist of PDE2 and significantly enhance the cAMP and cGMP hydrolytic activities of PDE2[1][2]. |
| CAS | 129693-10-3 |
| Formula | C12H11Cl2N2O6P |
| Molar Mass | 381.11 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. McMartin L, et al. Functional analysis of desensitization of the β‐adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion[J]. British journal of pharmacology, 1999, 127(4): 1012-1020. [2]. Jäger R, et al. Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5[J]. British journal of pharmacology, 2010, 161(7): 1645-1660. |
5,6-DCl-cBIMP
CAS: 129693-10-3 F: C12H11Cl2N2O6P W: 381.11
5,6-DCl-cBIMP, a cyclic adenosine monophosphate analog, can act as an agonist of PDE2 and significantly enhance the cAMP
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.